Study of VIR-2482 in Healthy Volunteers

NCT04033406 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza A

Interventions

DRUG: VIR-2482
DRUG: Placebo

Sponsor

Vir Biotechnology, Inc.